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Abstract. The review provides the information on the spectrum of microorganisms initiating the 
development of clinical and morphological forms of pancreatogenic infections. It is shown that 
when analyzing pathological conditions, no features in the microbiological landscape of the 
secondary infection in the pancreas and the surrounding extraperitoneal cellular tissue are 
registered. It provides the information on the particular structure of the microorganisms spectrum 
in acute pancreatitis in the Italian, Mexican, Indian, Chinese and Russian patient populations. 
Special attention has been paid to the choice of antibacterial medications in acute pancreatitis; the 
choice is based on sensitivity of allocated microorganisms to these medications, and 
particularities of medication therapeutic concentrations formation in the pancreas tissues or its 
secret. Foreign researchers’ experimental and clinical data regarding the penetration degree of 
various antibacterial agents into pancreatic tissue in the presence of pancreatic necrosis and 
efficiency of the agents in the process of drug correction of necrotizing pancreatitis. The analyzed 
information predetermines the need for a continuous microbiological pattern monitoring on the 
local level in association with assessment of its sensitivity and specificity to the prescribed 
antibacterial therapy of acute pancreatitis in the early stages of its infectious complications. 
Keywords: pancreatic necrosis, pancreatogenic infection, antimicrobial agents, antibiotic 
resistance, penetration of antimicrobial agents into the pancreas 
Infectious pancreatic necrosis and 
pancreatogenous abscess are the main clinical and 
morphological forms of pancreatogenic infections. 
Infectious pancreatic necrosis develops within about 
2 weeks, pancreatic abscess – within 5 weeks since 
the disease starts. According to some reports, 
infection of the pancreas and the surrounding 
retroperitoneal fat is revealed by 3 to 4 days. 
Nowadays it is known that deaths occur less 
frequently in case of pancreatogenic infection 
development later than within 3 weeks rather than in 
case of secondary infection until 3 weeks [15]. 
The literature tells that a range of 
microorganisms is mostly presented by 
microorganisms of the Enterobacteriacae group - 
Escherihia coli, Klebsiella pneumonia and rarer by 
other representatives of the family; Pseudomonas 
aeruginosa by Gram-positive organisms – 
staphylococci, streptococci, and enterococci. In 
association with aerobic organisms, anaerobic 
organisms Bacteroides spp. and clostridia are 
registered [3, 4, 23, 28, 31]. The authors have not 
found out dependence of microorganism spectrum 
discharge on type of pancreatogenic infection. It 
should be noted that, according to Isenmann R. et al., 
patients with infected pancreatic necrosis have more 
Candida spp., with detection frequency 5 to 15%, 
compared to other intraabdominal infections [20]. 
When studying etiology of severe acute 
pancreatitis in Italy, a mixed flora has been detected 
among 68% patients. Pseudomonas aeruginosa (59%) 
associated with Candida albicans or C. glabrata has 
been the most frequent representative [17]. 
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When studying a structure of the microorganism 
spectrum in case of acute pancreatitis in Mexico, 
staphylococci have been detected in most cases 
which is related by the researchers with alcohol 
ingestion [22]. 
418 (70.4%) strains of 594 ones which have 
been isolated by Chinese researchers in patients with 
acute destructive pancreatitis have been represented 
by gram-negative bacteria, 142 (23.9%) – by gram-
positive ones and 34 (5.7%) – by fungi. Escherichia 
coli (19.8%) as well as Pseudomonas aeruginosa 
(13.0%) and Acinetobacter baumannii (11.8%) have 
been the most frequently detected gram-positive 
bacteria. Enterococcus faecium (10.1%), coagulase-
negative staphylococci (5.4%) and Enterococcus 
faecalis (2.9%) have prevailed in the structure of the 
gram-positive flora [30]. 
When assessing the structure of causative agents 
and its dynamics in case of pancreatic necrosis 
among 51 patients, Indian researchers have found the 
agent in 37.3% patients; one agent has been found 
out in 27.5% patients and polymicrobial infection has 
been revealed in 9.8% patients. Within a first week of 
admission, colibacillus has been found out in 6 
patients of 6 (100%), within a second week of 
treatment, it has been revealed in 5 of 8 patients 
(62.5%), and after week two – in 2 of 5 patients 
(40.0%). In total, 32 (62.7%) patients have had signs 
of extrapancreatic infection with 53 positive cultures. 
Staphylococcus has been mostly found in blood 
cultures. A study of sensitivity of the detected 
microorganisms has shown that most bacteria have 
been sensitive to beta-lactam antibiotics, 
aminoglycosides, and imipenem. The authors think 
that the after-treatment results in changing the 
microflora structure from gram-negative to gram-
positive agents [24]. 
When studying a spectrum of agents discharged 
from bile, Romanian researchers have revealed that 
in case of antibiotic prophylaxis Escherichia coli has 
been found in 25 patients (42%) while it has been 
found in 14 patients (27%) of the control group; 
Klebsiella pneumoniae has been found in 6 patients 
(10%) and in 4 patients (8%); Enterococcus spp. has 
been found in 8 patients (13%) and in 11 patients 
(21%) respectively. Pseudomonas aeruginosa has 
been found only in the group of patients who had 
antibiotic prophylaxis – in 3 cases (5%) [32]. 
Belgian researchers have found out that 
bloodstream infections have occurred in 15% of 45 
examined patients with severe acute pancreatitis. 
When analyzing a structure of agents, 
microorganisms of gram-positive flora have prevailed 
– 57% isolated strains. Gram-negative 
microorganisms have been found in 35% cases, fungi 
have been found in 8% cases. Relation of the 
bloodstream infection with the pancreas necrotic 
discharge has been shown [33]. 
Data on etiology of main pancreotogenic 
peritonitis agents differ a bit by home authors. In the 
Russian Federation, main agents of infectious 
complications in destructive pancreatic necrosis are 
Enterobacteriaceae bacteria – 24 to 58% (in 
particular, Escherichia coli – 17 to 35%, and 
Klebsiella pneumonia – 5 to 24%, other 
Enterobacteriacae bacteria – 15 to 30%), 
Pseudomonas aeruginosa – 11 to 16%, streptococci – 
8 to 11%, staphylococci – 5 to 15%, enterococci –  
3 to 40%, Bacteroides spp. and anaerobic bacteria – 
17 to 48%, Candida fungi – in 5 to 37% cases [2, 4]. 
According to the results of researches in some 
regions of the Russin Federation, the predominant 
microorganisms are gram-negative Enterobacteriacae 
microorganisms: Escherichia coli (16%), Klebsiella 
pneumoniae (16%), Proteus mirabilis (5%), 
Enterobacter aerogenes (2%), Serratia marcescens 
(2%). Pseudomonas aeruginosa has been found in 7 
cases (19%), Acinetobacter baumannii – in 2 cases 
(4%) [5]. 
The results of studying sensitivity of isolated 
strains have shown that Enterobacteriacae 
microorganisms have kept sensitivity to carbapenems 
[2, 4, 5, 8]. However, according to the data of the 
multicenter epidemiological study of antibiotic 
resistance of nosocomial infection agents 
(MARATHON), resistance to meropenem, 
imipenem, and ertapenem in 2.8, 8.4 and 14.0% 
isolates respectively, mostly it has been  
K. pneumonia. The carbapenemase products of 
groups OXA-48 (3.3%) and NDM-1 (0.4%) have 
been found in 3.7% isolates [10]. 
Rate of extended spectrum beta lactamases 
(ESBL)-producing and cephalosporin-resistant strains 
which have been isolated from the patients with 
complicated intraabdominal infections and pancreatic 
necrosis has been up to 59% isolated strains of 
enterobacteria [1]. Level of enterobacteria resistance 
to amikacin has differed according to the data of 
various authors: 50 to 100% sensitive strains have 
been shown [1, 5]. Fluoroquinolones have shown low 
activity. Ciprofloxacin- and levofloxacin-resistant 
strains have been found in 55 to 67% cases among 
Escherihia coli and Klebsiella pneumoniae [1, 5, 8]. 
The multicenter epidemiological study 
MARATHON has revealed a rise of 
Enterobacteriacae strains producing extended 
spectrum beta lactamases (ESBL) up to 78.2%, 
90.6% – among Klebsiella pneumoniae, 82.1% – 
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among Escherihia coli. Level of resistance to 
gentamicin has reached 60.4%, to ciprofloxacin – 
70.5% and to trimethoprim/sulfamethoxazole – 
63.7%. Among non-beta lactam antibiotics,the most 
efficient ones have been amikacin, fosfomicin and 
tigecycline, resistance to which has been shown in 
36.1%, 14.1% and 15.9% isolates respectively [10]. 
A prevalence study of gram-negative bacteria 
producing metallo-beta-lactamase (MBL) has shown 
increase of the rate of MBL-positive Pseudomonas 
aeruginosa isolates (4.5 to 20.3% within 2002-2004 
and 2006-2007) in Russia (in 1998 to 2010), 
Belorussia and Kazakhstan (in 2005 to 2010) [11]. 
When studying Pseudomonas aeruginosa 
sensitivity in patients with pancreatic necrosis in 
some regions of the Russian Federation, 57% isolated 
strains of Pseudomonas aeruginosa have shown 
resistance to ceftazidime, cefoperazone and cefepime. 
Carbapenems have shown a bit higher activity: 57% 
strains have proved to be resistant to meropenem, 
42% strains – to imipenem/cilastatin. When 
analyzing data on associated resistance of 
carbapenem-resistant strains, it has been revealed that 
3 strains (42%) have proved to be sensitive to 
cefepime and ceftazidime (28%). Pseudomonas 
aeruginosa has shown high sensitivity to 
aminoglycosides. Resistance to amikacin has been 
found in 14% cases only, and to gentamicin – in 27% 
cases. Pseudomonas aeruginosa isolated strains have 
shown high level of resistance to fluoroquinolones: it 
has been isolated 72% strains resistant to 
ciprofloxacin, 82% strains resistant to levofloxacin 
[5]. Lack of absolute meropenem-imipenem cross-
resistance could be related to particularities of 
resistance acquisition by P. аeruginosa [9]. 
Detection frequency and sensitivity of gram-
positive microorganisms in Russia have been much 
lower compared to other regions in the world: 
Staphylococcus aureus has been found in 11.5% 
cases. Level of methicillin-resistant Staphylococcus 
aureus has been 7.1%; Staphylococcus epidermidis – 
4.8%, Enterococcus spp. – 4.8%. [7]. 
The gram-positive flora has been represented by 
strains of Staphylococcus aureus and coagulase-
negative staphylococcus and has differed, according 
to the data of various authors, in 15 to 27% isolated 
strains while 63% strains have been methicillin-
resistant [3, 5, 30]. 
In case of acute necrotizing pancreatitis, it is 
widely accepted to choose antimicrobial drugs resting 
on results of discharged microorganisms’ sensitivity 
assessment and particularities of forming a curative 
concentration of antibacterial medications in tissues 
or secretion of the pancreas. 
To simulate acute pancreatitis, several models 
have been used: with induction of bile acid 
intraductal injections [13], with standardized 
intraductal infusion of glycodeoxycholic acid and 
intravenous infusion of caerulein [27], by pancreatic 
duct ligation followed by injection of proserin [6]. 
The experimental study of antimicrobial drug 
penetration in the pancreas tissue in rats without 
signs of affected pancreas has shown that a 
tissue/plasma ratio for amikacin has been 16%, for 
amoxicillin/clavulanic acid – 24%, for piperacillin – 
27%, for ofloxacin – 59%, and for cefoperazone – 
108%. The tissue/plasma ratio in rats in the presence 
of pancreatitis simulation has been 7%, 23%, 26%, 
52% and 70% respectively [29]. 
High penetration of cefepime and meropenem in 
the pancreas tissue has been shown in rats with acute 
pancreatitis. Meropenem has had precedence over 
cefepime in penetrability into pancreas necrotic 
tissue, however both medications have made curative 
concentration in pancreas tissues [26]. 
The study of imipenem and cefotaxime 
penetration in 6 and 48 hours after simulating acute 
pancreatitis in rats has shown that imipenem has been 
accumulated at the initial stage of acute necrotic 
pancreatitis, has been marked by prominent edema 
and pancreatic capillary bloodstream depression, and 
has tended to reduce acinar cells in the course of the 
disease while solving the edema and necrosis 
progressing. Low concentration of cefotaxime has 
been found in the pancreas edematous tissue early 
after induction of acute necrotic pancreatitis and 
increase of the concentration has been revealed upon 
edema solution and pancreatic capillary bloodstream 
resetting [21]. 
The study conducted by Italian researches has 
shown a high penetration of imipenem, pefloxacin 
and metronidazole into the pancreas tissues in 
patients with pancreatic necrosis, while in case of 
prescribing aminoglycosides the penetration has been 
insufficient, which should be considered when 
prescribing antimicrobial therapy of pancreatic 
necrosis [14]. 
The study of ciprofloxacin concentration in 
pancreas necroses, peripancreatic necroses of fatty 
tissues and lesser sac fluid in patients with pancreatic 
necrosis has suggested ciprofloxacin efficiency when 
developing a preferable curative organ concentration 
of the drug in the course of medication correction of 
necrotic pancreatitis. The mean ratio of ciprofloxacin 
penetration has been 137.5% into lesser sac fluid, 
59.6% (3 to 214%) in pancreas necroses, and 67.1% 
(1 to 250%) in peripancreatic necroses [12]. 
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When comparing penetration of ciprofloxacin 
and ofloxacin into pancreatic juice after their single 
oral administration at a dose of 500 mg and 400 mg 
respectively in patients who had pancreas 
transplantation, it was shown that ofloxacin 
concentration has exceeded values of the minimal 
inhibitory concentration within several hours. 
Ciprofloxacin concentration has exceeded the 
minimal inhibitory concentration for a short time 
[16]. 
According to the data of German researches, 
after intravenous administration of ceftazidime at a 
dose of 35 mg/kg in patients with pancreatitis, 
ceftazidime concentration in pancreas tissues has 
varied 9 to 79% in the blood plasma. In five days 
after antibiotic administration at a dose of 2 grams 
three times per day, ceftazidime concentration has 
been 1.8 to 6.9 mg/kg including pancreas necrosis 
areas. The analysis of ceftazidime penetration into 
the pancreas has shown its potential efficiency in 
patients with acute necrotic pancreatitis which is 
related to development of the drug curative 
concentration in the pancreas tissues [18]. 
The study of meropenem penetration into 
pancreatic juice of the patients who underwent 
hepatobiliary and pancreatic surgery has shown that 
after 0.5-hour infusion of 500 mg meropenem its 
concentration in the pancreatic juice has been higher 
than the minimal inhibitory concentration for the 
most agents [19]. 
Tigecycline administration has shown a positive 
therapeutic and microbiological efficiency in 6 
patients with acute pancreatitis when curing 
pancreatic abscess and in case of extra-pancreatic 
infectious complications [25]. 
According to the results of numerous studies of 
preventive antimicrobial use efficiency, quite 
contradictory data have been obtained. The meta-
analysis made in Germany has revealed no proof of 
death reduction and infectious pancreatic necrosis 
rate decrease in case of preventive antimicrobial 
administration [34]. 
Another meta-analysis made in China has shown 
the advantage of preventive antimicrobial 
administration associated with true reduction of 
pancreatic infection, peripancreatic infectious 
complications and extra-pancreatic infections as well 
as with the length of hospital stay while it has shown 
no influence on death cases and surgery necessity in 
case of acute necrotic pancreatitis [35]. 
Thus, regarding pancreatic infection clinic in 
case of pancreatic necrosis, population and 
geographic microbiological particularities of the 
diseases under research have importance both in 
etiology and choise of efficient antimicrobial 
treatment. 
The mentioned studies have predetermined the 
necessity of continuous local monitoring of the 
microbiological flora in association with assessment 
of the flora sensitivity to the prescribed treatment of 
acute pancreatitis with early infectious complications 
considering the level of antimicrobial 
chemotherapeutic drug penetration into the pancreas. 
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